1Bruner CR, Feldman SR, Ventrapragada M, et al. A sys- tematic review of adverse effects associated with topical treatments for psoriasis [ J ]. Dermatol Online J, 2003,9 (1) :2.
2Ferenee JD, Last AR. Choosing topical eortieosteroids [ J ]. Am Faro Physician ,2009,79 (2) : 135-140.
3Gebhardt C, Averbeek M, Diedenhofen N, et al. Dermal hyaluronan is rapidly reduced by topieal treatment withglucocorticoids[ J ]. J Invest Dermatol, 2010, 130 ( 1 ) : 141-149.
5Bhawan J, Grimes P, Pandya AG, et al. A histological ex- amination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin O. 05% cream[J]. Am J Dermatopathol,2009, 31(8) :794-798.
6Hengge UR, Rnzieka T, Schwartz RA, et al. Adverse effects of topical glucocorticosteroids [ J ]. J Am Acad Der- matol,2006,54( 1 ) : 1-15.
7Spoerl D, Scherer K, Bircher AJ. Contact urticaria with systemic symptoms due to hexylene glycol in a topical cor- ticosteroid: case report and review of hypersensitivity to glycols [ J ]. Dermatology, 2010,220 (3) : 238 - 242.
8Tohgi N, Eto H, Maejima H, et al. Allergic contact derma- titis induced by topical hydrocortisone butyrate propionate mimicking acute generalized exanthematous pustulosis [ J ]. Eur J Dermato1,2009,19 ( 5 ): 518-519.
9Barbaud A. Contact dermatitis due to topical drugs. G hal Dermatol Venereol [ J ]. 2009,144 ( 5 ) : 527-536.
10Chang SE, Lee DK, Choi JH, et al. Majocehi's granuloma of the vulva caused by Trichophyton mentagrophytes [ J ]. 2005,48 (6) : 382-384.
